相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study
Neil P. Shah et al.
LEUKEMIA & LYMPHOMA (2020)
The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
Raffaella Pippa et al.
CELLS (2020)
Response to Comment on PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia
Damian Lai et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression
Deepika Raman et al.
REDOX BIOLOGY (2019)
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
Lingdi Zhang et al.
NATURE COMMUNICATIONS (2018)
Dasatinib: A Review in Pediatric Chronic Myeloid Leukemia
Emma H. McCafferty et al.
PEDIATRIC DRUGS (2018)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
Chao Hu et al.
SCIENTIFIC REPORTS (2017)
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
Jaya Sangodkar et al.
FEBS JOURNAL (2016)
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells
Bing Z. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential
Christopher S. Hong et al.
CANCER BIOLOGY & THERAPY (2015)
PP2A inhibitors arrest G2/M transition through JNK/Sp1-dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21
Fei-Ran Gong et al.
ONCOTARGET (2015)
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53
Francois H. T. Duong et al.
CARCINOGENESIS (2014)
The basic biology of PP2A in hematologic cells and malignancies
Dorien Haesen et al.
FRONTIERS IN ONCOLOGY (2014)
PP2A: the Achilles heal in DS with 5q deletion
David A. Sallman et al.
FRONTIERS IN ONCOLOGY (2014)
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Parthasarathy Seshacharyulu et al.
CANCER LETTERS (2013)
Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options
Elias J. Jabbour et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Protein phosphatase 2A: a target for anticancer therapy
Danilo Perrotti et al.
LANCET ONCOLOGY (2013)
Development of an Effective Therapy for Chronic Myelogenous Leukemia
David W. Woessner et al.
CANCER JOURNAL (2011)
Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis
Wei Li et al.
CANCER SCIENCE (2010)
Chronic myeloid leukemia: mechanisms of blastic transformation
Danilo Perrotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Dasatinib in chronic myeloid leukemia: a review
Apostolia-Maria Tsimberidou
Therapeutics and Clinical Risk Management (2010)
Serine/Threonine Phosphatases: Mechanism through Structure
Yigong Shi
CELL (2009)
Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms
Jie Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)
Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Michael Steinberg
CLINICAL THERAPEUTICS (2007)
Expression and function of protein phosphatase PP2A in malignant testicular germ cell tumours
S. Schweyer et al.
JOURNAL OF PATHOLOGY (2007)
Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo
AL Bauman et al.
NATURE CELL BIOLOGY (2002)
Protein phosphatase inhibitors arrest cell cycle and reduce branching morphogenesis in fetal rat lung cultures
BK Taylor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
分享论文
